agalsidase beta
Selected indexed studies
- Agalsidase Beta. (, 2006) [PMID:29999661]
- Agalsidase-beta therapy for advanced Fabry disease: a randomized trial. (Ann Intern Med, 2007) [PMID:17179052]
- Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort study. (J Med Genet, 2018) [PMID:29437868]
_Worker-drafted node — pending editorial review._
Connections
agalsidase beta is a side effect of
Sources
- Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study. (2024) pubmed
- Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort study. (2018) pubmed
- Agalsidase Alfa. (2006) pubmed
- Agalsidase Beta. (2006) pubmed
- Agalsidase-beta therapy for advanced Fabry disease: a randomized trial. (2007) pubmed
- Clinical outcomes in patients switching from agalsidase beta to migalastat: A Fabry Registry analysis. (2024) pubmed
- Agalsidase Beta: a review of its use in the management of Fabry disease. (2007) pubmed
- Spotlight on agalsidase beta in Fabry disease. (2007) pubmed
- New insights in efficacy of different ERT dosages in Fabry disease: Switch and switch-back studies data following agalsidase beta shortage. Update of systematic review. (2023) pubmed
- Recall urticaria with infusion of agalsidase beta. (2023) pubmed